Predictive Oncology Inc. announced the successful development of predictive models for 21 unique compounds sourced from the University of Michigan's Natural Products Discovery Core, marking a ...
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...
Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
Artificial intelligence (AI) machine learning is transforming pharmaceutical drug discovery. Advances in deep learning, a subset of machine learning, is enabling researchers to identify patterns in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines. In spring 2024, CBER reported more ...
BigHat Biosciences, a protein therapeutics company that combines state-of-the-art AI models with a high-speed automated wet ...
Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback